Foyston Gordon & Payne Inc Reduces Position in Genpact Limited (NYSE:G)

Foyston Gordon & Payne Inc lowered its stake in Genpact Limited (NYSE:G) by 22.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 102,231 shares of the business services provider’s stock after selling 29,985 shares during the period. Foyston Gordon & Payne Inc owned 0.06% of Genpact worth $4,008,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. CWM LLC lifted its position in Genpact by 160.8% during the second quarter. CWM LLC now owns 952 shares of the business services provider’s stock valued at $31,000 after purchasing an additional 587 shares during the period. Venturi Wealth Management LLC lifted its holdings in shares of Genpact by 74.6% in the 3rd quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock valued at $103,000 after buying an additional 1,121 shares during the period. GAMMA Investing LLC boosted its stake in shares of Genpact by 221.3% in the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock worth $131,000 after buying an additional 2,293 shares during the last quarter. Centaurus Financial Inc. acquired a new stake in Genpact during the third quarter worth about $159,000. Finally, M&T Bank Corp purchased a new position in Genpact during the third quarter valued at approximately $206,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Price Performance

Genpact stock opened at $44.83 on Tuesday. The company has a market capitalization of $7.91 billion, a price-to-earnings ratio of 12.32, a price-to-earnings-growth ratio of 1.56 and a beta of 1.17. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. Genpact Limited has a 1 year low of $30.23 and a 1 year high of $47.98. The company’s 50 day simple moving average is $41.95 and its 200-day simple moving average is $37.49.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be issued a $0.1525 dividend. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend is Monday, December 9th. Genpact’s dividend payout ratio (DPR) is currently 16.76%.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at $12,407,545.60. The trade was a 3.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.80% of the stock is owned by insiders.

Analysts Set New Price Targets

G has been the topic of a number of recent analyst reports. TD Cowen increased their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a report on Friday, November 8th. BMO Capital Markets increased their price target on Genpact from $38.00 to $42.00 and gave the stock a “market perform” rating in a research report on Monday, August 12th. Jefferies Financial Group boosted their price objective on Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 9th. Needham & Company LLC increased their target price on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Genpact currently has a consensus rating of “Hold” and an average price target of $42.33.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.